1Azziz R,et al.The prevalence and features of the polycystic ovary syndrome in an unselected population.J Clin Endocrinol.Metab,2004,89(6):2745-2749.
2Wickenheisser J K,et al.Human ovarian theca cells in culture.Trends Endocrinol.Metab,2006,17(2):65-71.
3Escobar-Morreale H F,et al.The molecular-genetic basis of functional hyperandrogenism and the polycystic ovary syndrome.Endocr Rev,2005,26(2):251-282.
4Alvarez-Blasco F,et al.Prevalence and characteristics of the polycystic ovary syndrome in overweight and obese women.Arch Intern Med,2006,166(19):2081-2086.
5Lo J C,et al.Increased prevalence of gestational diabetes mellitus among women with diagnosed polycystic ovary syndrome:a population-based study.Diabetes Care,2006,29(8):1915-1917.
6Peppard,H R,et al.Prevalence of polycystic ovary syndrome among premenopausal women with type 2 diabetes.Diabetes Care,2001,24(6):1050-1052.
7Musso C,et al.Clinical course of genetic diseases of the insulin receptor (type A and Rabson-Mendenhall syndromes):a 30-year prospective.Medicine (Baltimore),2004,83(4):209-222.
8Stanciu I N,et al.Insulinoma presenting with hyperandrogenism:a case report and a literature review.J Intern Med,2003,253(4):484-489.
9Codner E and Escobar-Morreale H F.Hyperandrogenism and polycystic ovary syndrome (PCOS) in women with type 1 diabetes Mellitus.J Clin Endocrinol Metab,2007,92(4):1209-1216.
10Escobar-Morreale H F,et al.The polycystic ovary syndrome associated with morbid obesity may resolve after weight loss induced by bariatric surgery.J Clin Endocrinol Metab,2005,90(12):6364-6369.
